Report from the Health Ministers’ meeting this week in Vancouver B.C.

  VANCOUVER, January 20th, 2016 – Canadian Cancer Survivor Network President and CEO Jackie Manthorne and CCSN Health Policy Consultant  Louise Binder are in Vancouver for events taking place around Canada’s Health Ministers meeting. Manthorne and Binder are meeting with several of the Provincial and Territorial Health Ministers to present oncology patients views on important issue being discussed at the Ministers’ meeting.  Federal Health Minister

B.C. health minister says feds to join province’s bulk-buy drug alliance

By The Canadian Press January 19, 2016 11:30 AM VICTORIA – The federal Liberal government is set to join other Canadian provinces and territories in a bulk-buying drug program that aims to lower the cost of prescription medications. British Columbia's Health Minister Terry Lake revealed the news and says federal government participation in the program will greatly enhance the purchasing power of the pan-Canadian Pharmaceutical

Oncology Patient Groups Support Expanded Drug Access

Oncology patient groups support expanded drug access for those forgotten in the health care system because of where they live or lack of income.   We believe that a drug access program, often referred to as pharmacare, must fill the gap for Canadians who do not have adequate financial resources to access existing public systems or who are not presently included for coverage.  Also there

BLINCYTO is the First-and-Only Bispecific CD19-Directed CD3 T-Cell Engager (BiTE®) Immunotherapy Approved by Health Canada

Mississauga, ON. (January 12, 2016) – Amgen Canada Inc., today announced that Health Canada has granted conditional* approval of BLINCYTO™ (blinatumomab) for the treatment of adults with Philadelphia chromosome-negative (Ph-) relapsed or refractory B precursor acute lymphoblastic leukemia (ALL). With this approval, BLINCYTO™ becomes the first Health Canada-approved bispecific CD19-directed CD3 T-cell engager (BiTE®) antibody construct product, and the first single-agent immunotherapy to be approved

Health Ministers’ Meeting: Cancer Groups Support Improved Access for Cancer Patients Falling Between the Cracks

OTTAWA, January 20th, 2016 – Leading Canadian cancer groups, the Canadian Cancer Survivor Network (CCSN), Save Your Skin Foundation (SYSF), Life Saving Therapies Network (LSTN), Anal Cancer – A Bum Rap, Hair Donation Ottawa, Canadian CML Network, and GIST Sarcoma Life Raft Group Canada, have banded together to support the federal, provincial, and territorial Health Ministers as they meet in Vancouver this week to craft

Webinar – Colorectal & Anal Cancer

Watch this webinar on YouTube! View the slides on SlideShare! Colorectal & Anal Cancer from Canadian Cancer Survivor Network     Webinar Information This webinar featured Helene Hutchings, chair of Anal Cancer – A Bum Rap: Anal Cancer Support Group and of Hair Donation Ottawa, who spoke about colorectal and anal cancer. Topics included: •    Understanding colorectal and anal cancer, including symptoms, risk factors•    Treatment